Analysis and Reflection on the Roles of Pharmacists in the Prevention and Treatment of Community Infectious Diseases in Some Developed Countries

doi:10.16153/j.1002-7777.2022.11.017

Chinese Pharmaceutical Affairs ›› 2022, Vol. 36 ›› Issue (11) : 1328-1336. DOI: 10.16153/j.1002-7777.2022.11.017

Wen Ruirui, Xu Long, Zhu Wenjing

Author information +

History +

Abstract

Objective: To strengthen the understanding of the roles played by pharmacists in the prevention and treatment of infectious diseases in some developed countries, and learn from their experience in order to enhance the professional potential of Chinese pharmacists. Methods: By searching PubMed and CNKI for relevant literatures about pharmacists' roles in the prevention and treatment of infectious diseases and literature review, we summarized and compared the situations at home and abroad, so as to get enlightenment and put forward relevant suggestions. Results: Pharmacists in China have made some contributions in major infectious disease events, but the roles of pharmacists in infectious disease prevention and control has not been fully explored and played, comparing with some developed countries. Conclusion: To enhance the have of pharmacists in the prevention and treatment of infectious diseases in China, the government should give policy support, affirm the professional value of pharmacists and give them full rights to undertake the corresponding work of prevention and treatment of infectious diseases. At the same time, the higher pharmaceutical education needs to be reformed and improved, and the pharmacists' self-construction should be strengthened too.

Key words

pharmacists； infectious diseases； prevention； treatment； community pharmacy； social pharmacy

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

Wen Ruirui, Xu Long, Zhu Wenjing. Analysis and Reflection on the Roles of Pharmacists in the Prevention and Treatment of Community Infectious Diseases in Some Developed Countries[J]. Chinese Pharmaceutical Affairs, 2022, 36(11): 1328-1336 https://doi.org/10.16153/j.1002-7777.2022.11.017

References

[1] Anne Catherine Cunningham,HuiPohGoh,David Koh.Treatment of COVID-19:Old Tricks for New Challenges[J].Crit Care，2020，24：1-2.
[2] Yong Liu,Jinxiu Li,Yongwen Feng.Critical Care Response to a Hospital Outbreak of the 2019-NCoV Infection in Shenzhen[J].China Crit Care，2020，24：1-3.
[3] Jorge Félix,Diana Ferreira,Marta Afonso-Silva,et al.Social and Economic Value of Portuguese Community Pharmacies in Health Care[J].BMC Health Serv，2017，17：1-12.
[4] FIP.Community Pharmacy Section Vision 2020-2025 Pharmacists at the Heart of Our Communities[EB/OL].（2020-11-09）[2021-12-20].https://www.fip.org/files/CPS_vision_FINAL.pdf.
[5] Canadian Pharmacists’Association.“Blueprint for Pharmacy:Designing the Future Together”[EB/OL].（2020-11-09）[2021-12-20].http://www.blueprintforpharmacy.ca.
[6] Helen Boardman,Martyn Lewis,Peter Croft,et al.Use of Community Pharmacies:A Population-Based Survey[J].Journal of Public Health，2005，27（3）：254-262.
[7] C D Hepler,L M Strand.Opportunities and Responsibilities in Pharmaceutical Care[J].Am J Hosp Pharm，1990，47（3）：533-543.
[8] World Health Organization.The Role of the Pharmacist in the Health Care System[EB/OL].（1996）[2021-12-20].https://apps.who.int/iris/handle/10665/59169.
[9] Joanna C Moullin,Daniel Sabater-Hernández,Fernando Fernandez-Llimos,et al.Defining Professional Pharmacy Services in Community Pharmacy[J].Res Soc Adm Pharm，2013，9：989-995.
[10] Giorgia Della Polla,Concetta Paola Pelullo,Francesco Napolitano,et al.Knowledge,Attitudes,and Practices Towards Infectious Diseases Related to Travel of Community Pharmacists in Italy[J].International Journal of Environmental Research and Public Health，2020，17（6）：2147.
[11] Lakshmi Kumari.Role of Pharmacist in Improving the Knowledge and Prevention Practices of Dengue Among Selected Rural High School Children of Guntur District[J].International Journal of Research in Pharmaceutical and Nano Sciences，2015，4（4）：241-249.
[12] Centers for Disease Control Prevention.Ten Great Public Health Achievements-Worldwide,2001-2010[J].Morbidity and Mortality Weekly Report(MMWR)，2011，60：814.
[13] World Health Organization.Global Vaccine Action Plan 2011-2020[EB/OL].（2013-02-21）[2021-12-20].https://www.who.int/publications/i/item/global-vaccineaction-plan-2011-2020.
[14] J E Isenor,N T Edwards,T A Alia,et al.Impact of Pharmacists As Immunizers on Vaccination Rates:A Systematic Review and Meta-Analysis[J].Vaccine，2016，34：5708-5723.
[15] Ministry of Health,New Zealand.Pharmacist Vaccinators[EB/OL].（2019-06-08）[2021-12-21].ttps://www.health.govt.nz/our-work/preventative-healthwellness/immunisation/immunisation-programmedecisions/pharmacist-vaccinators.
[16] H LaetitiaHattingh,T FeiSim,R Parsons,et al.Evaluation of the First Pharmacist-Administered Vaccinations in Western Australia:A Mixed Methods Study[J].BMJ Open，2016，6：e011948.
[17] Laura A Rhodes,Dennis Williams,D Weber.Community Pharmacists As Vaccine Providers[J].Int J Health Governance，2017，22：167-182.
[18] Morgado M,Rolo S,Castelo-Branco M.Pharmacist Intervention Program to Enhance Hypertension Control:A Randomised Controlled Trial[J].Int J Clin Pharm，2011，33：132-140.
[19] Henderson KC,Hindman J,Johnson SC,et al.Assessing the Effectiveness of Pharmacy-Based Adherence Interventions on Antiretroviral Adherence in Persons with HIV[J].AIDS Patient Care STDS，2011，25：221-228.
[20] Esther T L Lau,Michelle E Rochin,Megan DelDot,et al.“There's No Touching in Pharmacy”:Training Pharmacists for Australia's First Pharmacist Immunization Pilot[J].Can J Hospital Pharmacy，2017，70：281.
[21] Michael D Hogue,John D Grabenstein,Stephan L Foster,et al.Pharmacist Involvement with Immunizations:A Decade of Professional Advancement[J].J Am Pharm Assoc，2006（46）：168-182.
[22] Michael Taitel,Ed Cohen,Ian Duncan,et al.Pharmacists As Providers:Targeting Pneumococcal Vaccinations to High Risk Populations[J].Vaccine，2011，29：8073-8076.
[23] Terrence E Steyer,Kelly R Ragucci,William S Pearson,et al.The Role of Pharmacists in the Delivery of Influenza Vaccinations[J].Vaccine，2004，22：1001-1006.
[24] Sarah A Buchan,Laura C Rosella,Michael Finkelstein,et al.Impact of Pharmacist Administration of Influenza Vaccines on Uptake in Canada[J].Can Med Assoc，2017，189：E146-152.
[25] John D Grabenstein.Daily Versus Single-Day Offering of Influenza Vaccine in Community Pharmacies[J].Am Pharm Assoc，2009，49：628-631.
[26] Daria J O'Reilly,Gord Blackhouse,Sheri Burns,et al.Economic Analysis of Pharmacist-Administered Influenza Vaccines in Ontario,Canada[J].Clinico Economics Outcomes Res，2018，10：655.
[27] FIP.An Overview of Current Pharmacy Impact on Immunization-A Global Report 2016[EB/OL].（2016-08）[2021-12-20].https://www.fip.org/files/fip/publications/FIP_report_on_Immunisation.pdf.
[28] Mary Richard Akpan,Raheelah Ahmad,Nada Atef Shebl,et al.A Reviewof Quality Measures for Assessing the Impact of Antimicrobial Stewardship Programs in Hospitals[J].Antibiotics(Basel)，2016，5（1）：5.
[29] O'Neill J.Tackling Drug-Resistant Infections Globally:Final Reportand Recommendations.The Review on Antimicrobial Resistance[EB/OL].（2017-05-22）[2021-04-18].http://amr-revie w.org/sites/default/files/16052 5_ Final%20pap er_with%20cov er.pdf.
[30] Javier Garau,Dave P Nicolau,Bj?rn Wullt,et al.Antibiotic Stewardship Challenges in the Management of CommunityAcquired Infectionsfor Prevention of Escalating Antibiotic Resistance[J].Glob Antimicrob Resist，2014，2（4）：245-253.
[31] Veroniek Spoorenberg,Marlies E J L Hulscher,Reinier P Akkermans,et al.Appropriate Antibiotic Use for Patients with Urinary Ttract Infections Reduces Length of Hospital Stay[J].Clin Infect Dis，2014，58（2）：164-169.
[32] M Ortega,F Marco,A Soriano,et al.Epidemiology and Prognostic Determinants of Bacteraemic Catheter-Acquired Urinary tract Infection in a Single Institution from 1991 to 2010[J].Infect，2013，67（4）：282-287.
[33] Lidia Dalfino,Francesco Bruno,Sergio Colizza,et al.Cost of Care and Antibiotic Prescribing Attitudes for CommunityAcquired Complicated Intra-Abdominal Infections in Italy:Aretrospective Study[J].World J Emerg Surg，2014，9：39.
[34] Bryan M Bishop.Antimicrobial Stewardship in the Emergency Department:Challenges,Opportunities,and a Call to Action for Pharmacists[J].Pharm Pract，2016，29（6）：556-563.
[35] P Howard,C Pulcini,G Levy Hara,et al.An International Cross-Sectional Survey of Antimicrobial Stewardship Programmes in Hospitals[J].Antimicrob Chemother，2015，70（4）：1245-1255.
[36] Timothy H Dellit,Robert C Owens,John E McGowan Jr,et al.Infectious Diseases Society of America and the Societyfor Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship[J].Clin Infect Dis，2007，44（2）：159-177.
[37] European Centre for Disease Prevention and Control.Proposals for EU Guidelines on the Prudent Use of Antimicrobials in Humans[EB/OL].（2017-05-23）[2021-12-18].http://ecdc.europa.eu/en/publications/Publications/EU-guidelines-prudent-use-antimicrobials.pdf.
[38] Javier Garau，Matteo Bassetti.Role of Pharmacists in Antimicrobial Stewardship Programmes[J].International Journal of Clinical Pharmacy，2018，40（5）：948-952.
[39] Mark Gilchrist,Paul Wade,Diane Ashiru-Oredope,et al.Antimicrobial Stewardship from Policy to Practice:Experiences from UK Antimicrobial Pharmacists[J].Infect Dis Ther，2015，4（Suppl 1）：51-64.
[40] Kokta N.Antimicrobial Stewardship:How the Community Pharmacist Can Help.Inside Pharmacy[EB/OL].（2017）[2021-12-18].http://www.insidepatientcare.com/issues/2017/january-2017-vol-5-no-1/452-antimicrobial-stewardship-how-the-communitypharmacist-can-help.
[41] FIP.Fighting Antimicrobial Resistance:the Contribution of Pharmacsists[EB/OL].（2017-09-18）[2021-12-18].https://www.fip.org/files/fip/publications/2015-11-Fighting-antimicrobial-resistance.pdf.
[42] K T Ang,I Rohani,C H Look.Role of Primary Care Providers in Dengue Prevention and Control in the Community Institute for Health Management[J].Med J Malaysia，2010，65（1）：58-62.
[43] Thomas W F Chin,Clarence Chant,Rosemary Tanzini,et al.Severe Acute Respiratory Syndrome(SARS):The Pharmacist's Role[J].Pharmacotherapy，2004，24（6）：705-712.
[44] Adeel Abbas Dhahri,Sohail Yousuf Arain,Ayesha Majeed Memon,et al.The Psychological Impact of COVID-19 on Medical Education of Final Year Students in Pakistan:A Cross-Sectional Study[J].Ann Med Surgery,2020，60：445-450.
[45] Katie Louiselle,E Claire Elson,Alexandra Oschman,et al.Impact of COVID-19 Pandemic on Pharmacy Learners and Preceptors[J].Am J Health-System Pharm，2020，77（14）：1097-1099.
[46] Long Meng,Feng Qiu,Shusen Sun.Providing Pharmacy Services at Cabin Hospitals at the Coronavirus Epicenter in China[J].Int J Clin Pharm，2020，42（2）：305-308.
[47] Sean Wei Xiang Ong,Yian Kim Tan,Po Ying Chia,et al.Air,Surface Environmental,and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2(SARS-CoV-2)from a Symptomatic Patient[J].Jama，2020，323（16）：1610-1612.
[48] Céline Mongaret,Pauline Quillet,Thi Ha Vo,et al.Predictive Factors for Clinically Significant Pharmacist Interventions at Hospital Admission[J].Medicine，2018，97（9）：e9865.
[49] Sheng-Lan Tan,Bi-Kui Zhang,Ping Xu.2020,Chinese Pharmacists' Rapid Response to the COVID-19 Outbreak[J].Am J Health Syst Pharm，2020，77（14），1096-1097.
[50] Autumn D Zuckerman,Pratish C Patel,Mark Sullivan,et al.From Natural Disaster to Pandemic:A Health-System Pharmacy Rises to the Challenge[J].Am J Health Syst Pharm，2020，77（23）：1986-1993.
[51] Tareq L Mukattash,Anan S Jarab,Rana K Abu-Farha,et al.Willingness and Readiness to Test for COVID-19;A Qualitative Exploration of Community Pharmacists[J].Int J Clin Pract，2020，74：e13620.
[52] Tamam El-Elimat,Mahmoud M Abu Al Samen,Basima A Almomani,et al.Acceptance and Attitudes Toward COVID-19 Vaccines:A Cross-Sectional Study from Jordan[J].PLoS One，2021，16（4）：e0250555.
[53] Mukattash T,Jarab A,Abu Farha R,et al.Pharmacists' Perspectives on Providing the COVID-19 Vaccine in Community Pharmacies[J].Journal of Pharmaceutical Health Services Research，2021，12（2）：313-316.
[54] 都丽萍，张波.突发重大传染病事件中的药品保障和药学支持[J].临床药物治疗杂志，2020，18（3）：84-88.
[55] 刘璇，李为，刘宇.新型冠状病毒肺炎疫情下慢病患者药品获取途径与思考[J].中国药业，2020，29（10）：24-26.
[56] 张兰，张堃，褚燕琦，等.新型冠状病毒肺炎疫情下加快开展智慧药学服务的专家共识（第一版）[J].临床药物治疗杂志，2020，18（2）：4-9.
[57] 林志健，张冰.临床中药师参与新型冠状病毒肺炎（COVID-19）防治的药学服务策略[J].中国中药杂志，2020，45（6）：1259-1262.
[58] 高洋洋，徐珽，金朝辉，等.新冠肺炎疫情期间基于互联网医药模式的门诊药学服务实践与探讨[J].中国医院药学杂志，2020，40（6）：606-611.
[59] 李作吉，孙桂臻，赵桂红.药学保健在传染病防治中的实施策略探讨[J].中国当代医药，2014，21（26）：168-170.
[60] 杨志伟.药师查房七年回顾[J].中国当代医药，2009，16（3）：62-63.
[61] 韩晋，吴荣荣.传染病医院开展临床药学工作的实践与体会[J].中国药房，2008，19（29）：2015-2016.
[62] 郝言.传染病医院药物咨询服务的探讨及分析[J].中国药事，2013，28（3）：342-344.
[63] 国家药品监督管理局执业药师资格认证中心.2022 年6月全国执业药师注册情况[EB/OL].（2022-07-11）[2022-07-19].http://www.cqlp.org/info/link.aspx?id=6192&page=1.
[64] 李伟，酒励.美国执业药师参与疫苗管理的经验介绍及启示[J].中国药房，2016，27（25）：3457-3460.
[65] FIP.Sustainability[EB/OL].（2011-06）[2021-12-01].Https://www.fip.org/file/1439.
[66] 屈建，刘高峰，朱珠.新中国70周年医院药学的发展历程与趋势（Ⅱ）[J].中国医院药学杂志，2020，40（1）：1-22.
[67] FIP.Joint FIP/WHO Guidelines on Good Pharmacy Practice[EB/OL].（2012）[2021-12-20].https://www.fip.org/files/fip/WHO/GPP%20guidelines%20FIP%20 publication_final.pdf.